Affomix to Select mAbs for Kalgene Pharma

Affomix will use its Y2HExpress technology to select antibodies for Kalgene with potential diagnostic and therapeutic use in breast cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.